Autonomic and Enteric Profiling May Help Predict Response to Diverse Obesity Therapies

Area of Science:

• Physiology
• Obesity Research
• Gastroenterology

Background:

• Obesity is a complex condition potentially influenced by the autonomic nervous system (ANS) and enteric nervous system (ENS).
• Understanding the role of these systems may offer new avenues for obesity treatment.
• Predictive markers for diverse weight loss therapies are needed.

Purpose of the Study:

• To investigate if baseline autonomic and enteric nervous system parameters can predict the outcomes of various obesity therapies.
• To explore the relationship between ANS and ENS function and weight loss efficacy.

Main Methods:

• A pilot study involving 37 patients undergoing medical, semi-invasive, or invasive weight loss therapies.
• Autonomic nervous system function was assessed via sympathetic adrenergic function tests (vasoconstriction, postural adjustment ratio).
• Enteric nervous system function was measured non-invasively using electrogastrogram (EGG).

Main Results:

• Invasive therapies yielded significantly greater weight loss (28.5%) compared to semi-invasive (9.1%) and non-invasive (4.4%) methods.
• Weight loss at 1-year (and up to 5-years) correlated with specific ANS measures: postural adjustment ratio (r=0.42), resting pulse amplitude (r=0.56), and EGG standing-to-rest difference (r=0.33).

Conclusions:

• Baseline autonomic and enteric function measures appear to correlate with weight loss achieved through diverse therapeutic approaches.
• Autonomic and enteric profiling shows potential clinical utility in evaluating and managing obesity.
• Larger, controlled trials are necessary to validate these findings and their clinical application.